LifeVantage (NASDAQ:LFVN) Downgraded to “Hold” at ValuEngine

ValuEngine cut shares of LifeVantage (NASDAQ:LFVN) from a buy rating to a hold rating in a research report released on Thursday morning, ValuEngine reports.

Shares of LifeVantage stock traded up $0.12 during trading hours on Thursday, hitting $11.24. The company’s stock had a trading volume of 81,767 shares, compared to its average volume of 92,464. LifeVantage has a 1-year low of $9.10 and a 1-year high of $17.08. The firm has a fifty day moving average price of $11.87. The firm has a market cap of $158.84 million, a P/E ratio of 22.04 and a beta of 0.66.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.01). LifeVantage had a return on equity of 33.86% and a net margin of 2.91%. The business had revenue of $56.01 million during the quarter. As a group, sell-side analysts expect that LifeVantage will post 0.52 EPS for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in LFVN. Wedge Capital Management L L P NC acquired a new stake in shares of LifeVantage in the second quarter worth $1,151,000. Acadian Asset Management LLC grew its holdings in LifeVantage by 25.4% during the 1st quarter. Acadian Asset Management LLC now owns 364,749 shares of the company’s stock valued at $5,211,000 after purchasing an additional 73,992 shares in the last quarter. Laurion Capital Management LP grew its holdings in LifeVantage by 94.4% during the 1st quarter. Laurion Capital Management LP now owns 95,447 shares of the company’s stock valued at $1,364,000 after purchasing an additional 46,347 shares in the last quarter. Strs Ohio acquired a new stake in LifeVantage during the 2nd quarter valued at $569,000. Finally, Alambic Investment Management L.P. grew its holdings in LifeVantage by 75.9% during the 1st quarter. Alambic Investment Management L.P. now owns 87,753 shares of the company’s stock valued at $1,254,000 after purchasing an additional 37,867 shares in the last quarter. 37.39% of the stock is owned by institutional investors.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.

Recommended Story: What is meant by buying and selling pressure?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.